ArticleERJ open research2026
Healthcare professionals' perspectives on implementation of home monitoring in individuals with pulmonary fibrosis.
Article in ERJ open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Design of a randomized controlled trial comparing hybrid care with standard care for people with pulmonary fibrosis.Respiratory research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Home monitoring of physical parameters, symptoms and quality of life in individuals with pulmonary fibrosis (PF) could overcome gaps in clinical care by enabling early detection of disease progression, guiding patient management and improving access to specialised care. However, its global adoption in clinical practice is lacking. The aim of this study is to gain a deeper understanding of healthcare professionals' (HCPs) perspectives on implementing home monitoring for individuals with PF. Methods: Semi-structured interviews were conducted with HCPs. Transcripts were analysed through an inductive-deductive qualitative thematic analysis using the NASSS (nonadoption, abandonment, scale-up, spread and sustainability) framework, which provides a systematic method for examining barriers and facilitators that may hamper the implementation of technological innovations. Results: 30 HCPs from 18 interstitial lung disease clinics in the Netherlands were interviewed, reflecting varying levels of experience with home monitoring. They were positive towards the implementation of home monitoring for individuals with PF, favouring a tailored hybrid care approach. HCPs preferred incorporating home spirometry and alerts for signs of deterioration. Different barriers were identified to implement home monitoring and hybrid care pathways, including technical challenges, such as reduced reliability of home spirometry in certain patients and concerns about replacing care for progressive or unstable patients. HCPs emphasised the need for a coordinated hybrid care pathway and they advocated for strong evidence on cost-effectiveness and quality of hybrid care models. Discussion: Home monitoring is considered valuable in the management of PF. Identified preferences, barriers and facilitators can be used to inform strategies for sustainable implementation of home monitoring in clinical practice.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.